CI
56
-3
NTRS
67
2
MAR
77
3
CAG
31
2
TGT
52
-2
GRMN
43
-2
PNC
67
-4
WDC
58
3
MCK
66
2
BXP
38
4
SYK
44
-2
IRM
49
3
A
53
2
SIG
50
-8
AES
47
-2
AMGN
39
-7
LEN
38
12
MTB
69
-2
MS
76
2
AZO
48
8
CI
56
-3
NTRS
67
2
MAR
77
3
CAG
31
2
TGT
52
-2
GRMN
43
-2
PNC
67
-4
WDC
58
3
MCK
66
2
BXP
38
4
SYK
44
-2
IRM
49
3
A
53
2
SIG
50
-8
AES
47
-2
AMGN
39
-7
LEN
38
12
MTB
69
-2
MS
76
2
AZO
48
8
Financhill
Back

iShares Biotechnology ETF Stock Predictions

Meet America's Newest $1B Unicorn

DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Buy
67

IBB
iShares Biotechnology ETF

Last Price:
$172.40
Seasonality Move:
-0.63%

7 Day Trial

ALL ACCESS PASS

$ 7

Exxon and Chevron Have an Unlikely New Competitor

DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at

iShares Biotechnology ETF Stock Forecast

  • Over the next 52 weeks, iShares Biotechnology ETF has on average historically risen by 10% based on the past 24 years of stock performance.
  • iShares Biotechnology ETF has risen higher in 14 of those 24 years over the subsequent 52-week period, corresponding to a historical accuracy of 58.33%
  • Is iShares Biotechnology ETF Stock Undervalued?
    The current iShares Biotechnology ETF [IBB] share price is $172.39. The Score for IBB is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • IBB is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will iShares Biotechnology ETF Stock Go Up Next Year?

  • Over the next 52 weeks, iShares Biotechnology ETF has on average historically risen by 10% based on the past 24 years of stock performance.

iShares Biotechnology ETF Stock Rating

Buy
67
iShares Biotechnology ETF (IBB) is a Buy

Is iShares Biotechnology ETF overpriced?

  • iShares Biotechnology ETF has risen higher in 14 of those 24 years over the subsequent 52-week period, corresponding to a historical accuracy of 58.33%

iShares Biotechnology ETF Stock Price History

Is IBB stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IBB is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
179.64
52-Week Low:
107.43

Prediction Charts

Market Cap:
0
Price in USD:
172.39
Volume:
2.5M
Beta:
0.90

Technical Analysis

SMA50:
167.08
SMA100:
156.17
SMA200:
141.28
52-Wk Change:
27.86%

Stock Predictions

  • Is iShares Biotechnology ETF stock public?
    Yes, iShares Biotechnology ETF is a publicly traded company.
  • What is the iShares Biotechnology ETF stock quote today?
    The iShares Biotechnology ETF stock price is 172.39 USD today.
  • How to buy iShares Biotechnology ETF stock online?
    You can buy iShares Biotechnology ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-18 166.88 166.19 168.33 165.70
Dec-19 166.93 170.20 170.74 166.75
Dec-22 170.45 172.77 173.16 170.22
Dec-23 172.44 172.10 173.60 171.90
Dec-24 172.26 173.25 173.53 172.25
Dec-26 172.89 172.03 172.90 171.40
Dec-29 171.48 170.76 172.03 170.36
Dec-30 170.77 168.89 170.77 168.31
Dec-31 169.10 168.77 169.58 168.14
Jan-5 168.50 167.34 168.99 165.09
Jan-6 167.39 171.24 171.61 167.39
Jan-7 172.40 176.74 179.64 172.26
Jan-8 175.34 172.26 175.90 170.61
Jan-9 173.92 172.39 174.66 172.17

iShares Biotechnology ETF Earnings

Data Unavailable

iShares Biotechnology ETF Forecast Revenue Growth

Data Unavailable

* iShares Biotechnology ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.